 |
Two
new comments about Glycosmedia |
| |
One from Diabetes UK and another from the Institute
of Obesity, Nutrition and Exercise, University of Sydney. All readers
are invited to comment on Glycosmedia (Editor) |
| |
|
|
Disparity
of diabetes diagnosis in England |
| |
New figures show significant disparity of diabetes
diagnosis across Primary Care Trusts (PCTs) in England (Diabetes
UK) |
| |
|
|
Diabetes
patients face screening delays |
| |
Diabetes patients in Norfolk and Waveney could
be at increased risk of ulcers or even amputation because of long
waiting times for foot screening in the east of the area and the
loss of a specialised service in central Norfolk (EDP24, UK) |
| |
|
|
Continuous
Glucose Monitoring and Intensive Treatment of Type 1 Diabetes |
| |
Continuous glucose monitoring can be associated
with improved glycemic control in adults with type 1 diabetes.
Further work is needed to identify barriers to effectiveness of
continuous monitoring in children and adolescents (NEJM) |
| |
|
|
JDRF
Funded Trial Demonstrates Continuous Glucose Monitoring Can Help
People With Type 1 Diabetes Improve Blood Sugar Control |
| |
Initial results of a clinical trial in the USA,
showed that people with type 1 diabetes who used continuous glucose
monitoring (CGM) devices to help manage their condition, experienced
significant improvements in blood sugar control (JDRF) |
| |
|
|
Research
matters |
| |
Summer/Autumn 2008. 17-page PDF (Diabetes UK) |
| |
|
|
Effects
of fat supplementation on glycaemic response and gastric emptying
in adolescents with Type 1 diabetes |
| |
For the first time, we have shown that the initial
glycaemic response is reduced after a meal with higher compared
with a meal with lower fat content in adolescents with T1DM given
a rapid-acting insulin analogue preprandially (Diabetic Medicine) |
| |
|
|
National
Knowledge for Diabetic Retinopathy |
| |
Knowledge updates are available under the following
sub topics (14) of diabetic retinopathy (NLH, UK) |
| |
|
|
Xoma’s
Phase I biologic reduces glucose levels |
| |
US biotechnology company Xoma has presented
data from two early-stage trials which suggests that one of its
experimental antibodies can offer “a novel anti-inflammatory approach to type 2 diabetes treatment that may preserve
insulin-producing cells (PharmaTimes) |
| |
|
|
Blood
glucose control and cardiovascular disease in patients with type
2 diabetes. Results of ACCORD, ADVANCE and VA-Diabetes trials |
| |
In the three studies, the hypoglycaemic risk
was indeed increased in the intensive group, which may contribute
to reduce the positive impact of better glucose control on cardiovascular
complications (PubMed) |
| |
|
|
Campaign
aims to educate men about type 2 diabetes |
| |
Men with type 2 diabetes know the basics about
the disease and its main complications - heart disease, blindness,
kidney failure - but they seem to know very little about the issues
that affect their quality of life, like depression and sexual dysfunction,
according to results of a survey released today by the American
Diabetes Association (Reuters) |
| |
|
|
Approach
to the Patient with Prediabetes |
| |
This article will review some of the issues
surrounding the identification and treatment of prediabetes, with
an interpretation of the available data to help guide management
(Journal of Clinical Endocrinology & Metabolism) |
| |
|
|
Invitation
for Submissions |
| |
From time to time Diabetes Australia invites
written submissions on draft guidelines for diabetes management.
A list of those guidelines Diabetes Australia is currently inviting
submissions on is listed (Diabetes Australia) |
| |
|
|
Accelerated
senescence in the kidneys of patients with type 2 diabetic nephropathy |
| |
These changes are associated with shortening
tubular telomere length in vitro. These findings indicate that
diabetes may boost common pathways involving kidney cell senescence,
thus reinforcing the role of the metabolic syndrome on biological
ageing of tissues (American Journal of Physiology: Renal Physiology) |
| |
|
|
Insulet
Releases New OmniPod Software to Doctors |
| |
This week, without a lot of hoopla, Insulet
Corp. is rolling out a new software package for use in clinical
settings by Health Care Providers, called OmniPod Partner (Diabetes
Mine) |
| |
|
